UNSPSC 51171525: Magnesium oxide

This classification denotes a nutritional supplement and laxative, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3A3U0GI71G, chemically known as oxomagnesium, but generally known as magnesium oxide, which bears US NIH Compound Identifier 14792. European Medicines Agency schedules Magnesium oxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14436MIG. Magnesium oxide generally arises in the molecular formula MGO.

The term MAGNESIUM OXIDE is a United States Homeopathic Pharmacopoeia Name designation. As of Q4 2014, MAGNESIUM OXIDE remains the US FDA Preferred Term for this commodity. Magnesium oxide bears US NLM identifiers UMLS ID C0024477 and NCI Concept Code C29242. SMILES: O=[Mg].

UNSPSC 51171525 Magnesium oxide is a Commodity code that shows little relevant recent activity in state and local procurement. The three most recent opportunities posted under this code do not align with magnesium oxide procurement; instead, they cover offender drug testing services, pharmaceutical direct-to-manufacturer programs, and generic multi-source pharmaceuticals and OTC products. None of these solicitations involves magnesium oxide as a purchased material or input.

The mismatch between the code's nominal scope and actual posting activity suggests that either the tagging is erroneous or the code sees minimal legitimate use in state and local contracting. A business development professional evaluating this Commodity code should treat it as inactive for procurement purposes and verify any future opportunities against the actual statement of work rather than relying on the code classification alone.